Workflow
Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now
BIOBio-Rad(BIO) ZACKS·2024-08-22 13:16

Bio-Rad Laboratories, Inc. (BIO) is gaining investors' confidence due to its Digital PCR business, which boasts a strong pipeline. The company's Clinical Diagnostics arm is seeing increased demand for quality control, blood typing and diabetes products. Sound financial stability also appears encouraging. However, pricing pressure due to tough competition, along with adverse macroeconomic impacts, might deter Bio-Rad's growth. Persistent reduced demand in the Biopharma segment adds to the worry. Year to date ...